IP vs PLX
International Paper (IP) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
IP currently screens at market cap $26.62B and trailing P/E 43.1. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the IP and PLX stock pages for the full models.
Not investment advice.